Description
Specifications
| Form | Lyophilized powder, single vial |
| Size | 5 mg |
| Class | GHRH(1-29) analog with Drug Affinity Complex |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| CJC-1295 with DAC | C₁₆₅H₂₆₉N₄₇O₄₆ · MW 3647.3 · CAS 446262-90-4 |
How Is CJC-1295 with DAC Studied?
CJC-1295 with DAC is a modified GHRH(1-29) analog carrying a maleimidopropionyl Drug Affinity Complex that binds circulating albumin, extending its half-life well beyond unmodified GHRH analogs. Studies have examined its sustained GHRH receptor engagement and downstream GH and IGF-1 signaling.
Storage
Store the sealed vial at −20 °C long-term or 2–8 °C short-term, away from light. Once reconstituted in the lab, keep at 2–8 °C and avoid repeated freeze-thaw cycles. See our storage guide.
FAQ
How is this different from CJC-1295 without DAC?
The version without DAC has a much shorter half-life. It is available in the Ipamorelin / CJC-1295 (no DAC) blend.
Is a Certificate of Analysis available?
Yes. Tap “View Certificate of Analysis” on this page for the current lot’s third-party COA.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
